Cancer Family
Reproductive System Neoplasm
CI-CAN-00000338Explore in graph →
Non-malignant3,041 active trials38 approved drugs197 evidence items
- NCIt
- C3674
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000338Explore in graph →
Clinical trials
13,668 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT07469202 | CYTALUX Dose Extension Study | not yet recruiting | Phase 4 | 106 | On Target Laboratories, LLCINDUSTRY | 0 | Aug 18, 2026 | clinicaltrials |
| NCT07767266 | Neoadjuvant Pucotenlimab and Becotatug Vedotin for Locally Advanced Penile Cancer | not yet recruiting | Phase 2 | 29 | Sun Yat-sen UniversityOTHER | 1 | Aug 17, 2026 | clinicaltrials |
| NCT07768917 |
| Training on Systemic and Organ Spec. PM in PC |
| not yet recruiting |
| N/A |
| 20 |
| Massachusetts General HospitalOTHER |
| 1 |
| Aug 17, 2026 |
| clinicaltrials |
| NCT07769372 | Magnetic Resonance-Guided Stereotactic Body Radiation Therapy for the Treatment of Prostate Cancer | not yet recruiting | N/A | 20 | City of Hope Medical CenterOTHER | 1 | Aug 17, 2026 | clinicaltrials |
| NCT07733908 | Effectiveness of Posluma PET Scan for Post-Treatment Monitoring of Prostate Cancer | not yet recruiting | Phase 2 | 22 | Aditya BagrodiaOTHER | 0 | Aug 14, 2026 | clinicaltrials |
| NCT07737925 | LuX: Xaluritamig in Participants With Metastatic Castrate Resistant Prostate Cancer and Suboptimal Response to Lutetium 177 Vipivotide Tetraxetan | not yet recruiting | Phase 2 | 30 | Thomas Jefferson UniversityOTHER | 0 | Aug 14, 2026 | clinicaltrials |
| NCT07765940 | Safety and Preliminary Diagnostic Performance of [⁶⁴Cu]Cu-RAX301 in Prostate Cancer(COPRA424) | not yet recruiting | Phase 1 / Phase 2 | 52 | RadAlliance Therapeutics, IncINDUSTRY | 0 | Aug 14, 2026 | clinicaltrials |
| NCT07766122 | Analysis of the Performance of PSMA Emission Tomography in Patients With Prostate Cancer Treated With HIFU(ECETEP) | not yet recruiting | Phase 4 | 30 | University Hospital, ToulouseOTHER | 1 | Aug 14, 2026 | clinicaltrials |
| NCT07766603 | Preoperative Breathing Exercise Training and Postoperative Delirium After Robotic Radical Prostatectomy | not yet recruiting | N/A | 50 | ALİ DEMİRTAŞOTHER | 1 | Aug 14, 2026 | clinicaltrials |
| NCT07760857 | Investigation of an Intelligent Centre-adaptive Multi-modal Fusion Framework (Cad- MMFF) to Overcome Unnecessary Prostate Biopsies and Optimize MRI Utilization | not yet recruiting | — | 400 | Chinese University of Hong KongOTHER | 1 | Aug 12, 2026 | clinicaltrials |
| NCT07761416 | Opportunistic Salpingectomy During Bariatric Surgery for Ovarian Cancer Prevention | not yet recruiting | Early Phase 1 | 66 | St. Joseph's Healthcare HamiltonOTHER | 0 | Aug 12, 2026 | clinicaltrials |
| NCT07652164 | Water Vapor Ablation for Grade Group 3 Prostate Cancer(VAPOR 3) | not yet recruiting | N/A | 120 | Francis Medical Inc.INDUSTRY | 0 | Aug 11, 2026 | clinicaltrials |
| NCT07757711 | Implementation of New Models of Ovarian Carcinoma Resistant to Therapy | not yet recruiting | — | 50 | Mario Negri Institute for Pharmacological ResearchOTHER | 0 | Aug 11, 2026 | clinicaltrials |
| NCT07105020 | iCCARE Project #4: Grounded Theory Study of the Social Determinants of Migrant Health Factors Impacting Prostate Cancer Care and Survivorship Among Sub-Saharan African and Caribbean Immigrant Men Diagnosed With Prostate Cancer | not yet recruiting | N/A | 40 | M.D. Anderson Cancer CenterOTHER | 1 | Aug 10, 2026 | clinicaltrials |
| NCT07754877 | Safety and Efficacy of Microwave Ablation Alone Versus Microwave Ablation Combined With Chemical Ablation in the Treatment of Uterine Fibroids: A Prospective, Multicenter Study | not yet recruiting | N/A | 248 | Peking University Aerospace Center HospitalOTHER | 1 | Aug 10, 2026 | clinicaltrials |
| NCT07756593 | Sipuleucel-T (Sip-T) in Combination With N-803 in Metastatic Androgen Pathway Modulation Resistant (mAPMR) Prostate Cancer | not yet recruiting | Phase 1 | 30 | Washington University School of MedicineOTHER | 1 | Aug 10, 2026 | clinicaltrials |
| NCT07730125 | Gene-edited T Regulatory Cells (CRG-150) for the Treatment of Relapsed/Refractory Malignancies | not yet recruiting | Phase 1 / Phase 2 | 67 | CoRegen, Inc.INDUSTRY | 0 | Aug 7, 2026 | clinicaltrials |
| NCT07752875 | A Study of LG00313112 in Participants With Advanced Solid Malignancies Harboring a TP53 Y220C Mutation | not yet recruiting | Phase 1 / Phase 2 | 250 | LG ChemINDUSTRY | 0 | Aug 7, 2026 | clinicaltrials |
| NCT07753356 | VALIDATION OF FUSION CEMEP SCORE FOR OMITTING SYSTEMATIC PROSTATE BIOPSY(FUSION-CEMEP) | not yet recruiting | — | 150 | Marcelo Ruben OlivaOTHER | 1 | Aug 7, 2026 | clinicaltrials |
| NCT07716735 | Mercaptopurine for the Treatment of Hereditary Leiomyomatosis and Renal Cell Carcinoma (HLRCC), Uterine/Cutaneous Leiomyomas, and Kidney Cancer | not yet recruiting | Phase 1 | 18 | Jonsson Comprehensive Cancer CenterOTHER | 1 | Aug 6, 2026 | clinicaltrials |
| NCT06607874 | Self-Collection for Cervical Cancer Screening and HPV Vaccination for Cancer Prevention Among Women in Emergency Care in Northeast Florida | not yet recruiting | — | 100 | Mayo ClinicOTHER | 1 | Aug 5, 2026 | clinicaltrials |
| NCT07281547 | Low Dose Aspirin to Lower Inflammation and Prevent Endometrial Cancer in Postmenopausal Women With Non-atrophic Endometrial Changes and Pain | not yet recruiting | Phase 4 | 20 | Mayo ClinicOTHER | 1 | Aug 5, 2026 | clinicaltrials |
| NCT07743541 | Study of TUB-040 in Patients With Recurrent or Progressive Uterine Cancer After Chemotherapy and Immune Therapy(NAPISTAR 1-03) | not yet recruiting | Phase 1 / Phase 2 | 100 | Tubulis GmbHINDUSTRY | 1 | Aug 5, 2026 | clinicaltrials |
| NCT07746349 | Terlipressin vs Placebo to Reduce Bleeding in Fibroid Surgery | not yet recruiting | N/A | 80 | Sevil CankayaOTHER | 0 | Aug 5, 2026 | clinicaltrials |
| NCT07747493 | 68Ga-PSMA-11 PET/MRI for Selecting Men With Prostate Cancer for Focal Therapy(PSMA-FT) | not yet recruiting | N/A | 8 | University Health Network, TorontoOTHER | 1 | Aug 5, 2026 | clinicaltrials |
| NCT07747506 | Continued Access to Avutometinib in Combination With Defactinib in Patients With Recurrent Low-Grade Serous Ovarian Cancer (LGSOC) | not yet recruiting | Phase 2 | 2 | Verastem, Inc.INDUSTRY | 1 | Aug 5, 2026 | clinicaltrials |
| NCT07650448 | WATER IV PCa (AS Sub-study) | not yet recruiting | N/A | 333 | PROCEPT BioRoboticsINDUSTRY | 2 | Aug 4, 2026 | clinicaltrials |
| NCT07738315 | Elemene Liposomes in Endometrial Cancer | not yet recruiting | Phase 2 | 212 | Women's Hospital School Of Medicine Zhejiang UniversityOTHER | 1 | Jul 31, 2026 | clinicaltrials |
| NCT07739745 | Development Of An Endometrial Cancer Educational Tool | not yet recruiting | N/A | 250 | M.D. Anderson Cancer CenterOTHER | 1 | Jul 31, 2026 | clinicaltrials |
| NCT06786429 | Managing Hepatitis B (Hep. B) and Human Papilloma Virus (HPV) Related Cancers and Mental Health. | not yet recruiting | Phase 4 | 2,140 | Eunice DubeOTHER | 0 | Jul 30, 2026 | clinicaltrials |
| NCT07737457 | MICRO-ultrasound Guided Prostate SBRT(MICRO-S) | not yet recruiting | N/A | 112 | London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph'sOTHER | 1 | Jul 30, 2026 | clinicaltrials |
| NCT07737795 | Evaluating the Addition of OK-1 Weekly Paclitaxel in Patients With Endometrial Cancer | not yet recruiting | Phase 2 | 66 | University of OklahomaOTHER | 1 | Jul 30, 2026 | clinicaltrials |
| NCT07732686 | Analysis of Breath Volatile Organic Compounds Using Mass Spectrometry | not yet recruiting | — | 2,000 | University of OklahomaOTHER | 1 | Jul 29, 2026 | clinicaltrials |
| NCT07733440 | PROstate Cancer Risk Calculator for ACTionable Clinical Decision-making in Nigeria(PROACT) | not yet recruiting | N/A | 89 | Ahmadu Bello UniversityOTHER | 1 | Jul 29, 2026 | clinicaltrials |
| NCT07735273 | eMindExCare for Prostate Cancer Patients Undergoing Active Treatment(eMindExCare) | not yet recruiting | N/A | 60 | The University of Hong KongOTHER | 1 | Jul 29, 2026 | clinicaltrials |
| NCT07730151 | Efficacy and Safety of Darolutamide Combined With Docetaxel and ADT as Neoadjuvant Therapy for Locally Advanced Prostate Cancer. | not yet recruiting | Phase 2 | 200 | RenJi HospitalOTHER | 0 | Jul 28, 2026 | clinicaltrials |
| NCT07730580 | Study of XNW5004 Tablets in Advanced Prostate Cancer(XNW5004 Tablet) | not yet recruiting | Phase 2 | 242 | Evopoint Biosciences Inc.INDUSTRY | 0 | Jul 28, 2026 | clinicaltrials |
| NCT07731607 | Sintilimab Monotherapy in Patients With Stage I-II MSI-H/dMMR Endometrial Cancer | not yet recruiting | Phase 2 | 48 | Wang JianliuOTHER | 0 | Jul 28, 2026 | clinicaltrials |
| NCT07727473 | Preoperative Semaglutide Prior to Radical Prostatectomy | not yet recruiting | Early Phase 1 | 20 | Banner HealthOTHER | 1 | Jul 27, 2026 | clinicaltrials |
| NCT07690332 | A Real-world Study of Mirvetuximab Soravtansine (MIRV) in Ovarian Cancer Patients of Expression of Folate Receptor α（FRα）(MIRAS) | not yet recruiting | — | 400 | NING LI-GYNOTHER | 0 | Jul 24, 2026 | clinicaltrials |
| NCT07606287 | Studying the Workflow of the American College of Surgeons Geriatric Surgery Program to Improve Clinical Outcomes in Older Adults Undergoing Surgery at the James Cancer Hospital | not yet recruiting | N/A | 4,000 | Ohio State University Comprehensive Cancer CenterOTHER | 1 | Jul 23, 2026 | clinicaltrials |
| NCT07641855 | A Study of BL-B01D1 Combination Therapy in Patients With Metastatic Castration-resistant Prostate Cancer | not yet recruiting | Phase 2 / Phase 3 | 180 | Sichuan Baili Pharmaceutical Co., Ltd.INDUSTRY | 1 | Jul 23, 2026 | clinicaltrials |
| NCT07723235 | Web-based Lifestyle Program, mHealth and EMA Intervention, to Improve Weight Loss in Rural Stage I-III Postmenopausal Breast and Endometrial Cancer Survivors, HERO-C Trial | not yet recruiting | N/A | 90 | Ohio State University Comprehensive Cancer CenterOTHER | 1 | Jul 23, 2026 | clinicaltrials |
| NCT07723651 | [18F]Fluorthanatrace - Positron Emission Tomography (FTT-PET) and ctDNA to Predict Response to PARP Inhibitor Therapy in Metastatic Prostate Cancer (mPC) | not yet recruiting | Phase 2 | 75 | Washington University School of MedicineOTHER | 1 | Jul 23, 2026 | clinicaltrials |
| NCT07724080 | Resistance Exercise, IL-7 and Immune Phenotypes in Prostate Cancer | not yet recruiting | N/A | 40 | University of BathOTHER | 1 | Jul 23, 2026 | clinicaltrials |
| NCT07278362 | Testosterone Replacement Therapy in Hypogonadal Patients With Prostate Cancer Under Active Surveillance | not yet recruiting | Phase 4 | 35 | University of MiamiOTHER | 1 | Jul 22, 2026 | clinicaltrials |
| NCT07697989 | Pluvicto Real-world Investigation in Survival in Metastatic CRPC(PRISM) | not yet recruiting | — | 1,085 | Novartis PharmaceuticalsINDUSTRY | 0 | Jul 22, 2026 | clinicaltrials |
| NCT07720180 | Study of Autologous, Metabolically Optimized, CD137+ Tumor-Infiltrating Lymphocytes Followed by Consolidative Oral Cyclophosphamide, Bevacizumab, and Pembrolizumab(OVAFIT-TIL) | not yet recruiting | Phase 2 | 20 | Medical University of South CarolinaOTHER | 1 | Jul 22, 2026 | clinicaltrials |
| NCT07716800 | Predictors of Cognitive Decline and Delirium in Older Women With Ovarian Cancer(CROWN) | not yet recruiting | — | 205 | Fondazione Policlinico Universitario Agostino Gemelli IRCCSOTHER | 0 | Jul 21, 2026 | clinicaltrials |
| NCT07714070 | Orlistat Plus Progestin for Fertility-Sparing Treatment of Endometrial Cancer or Atypical Hyperplasia(PKUPH-ORLPP-EC) | not yet recruiting | Phase 2 | 48 | Peking University People's HospitalOTHER | 1 | Jul 20, 2026 | clinicaltrials |
Data updated 23 days agoSource updated Aug 18, 2026source: clinicaltrials